146 related articles for article (PubMed ID: 38545829)
1. Critical survival periods in prostate cancer in Sweden explored by conditional survival analysis.
Hemminki K; Zitricky F; Sundquist K; Sundquist J; Försti A; Hemminki A; Hemminki O
Cancer Med; 2024 Apr; 13(7):e7126. PubMed ID: 38545829
[TBL] [Abstract][Full Text] [Related]
2. Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964-2003 followed up until the end of 2006.
Bray F; Klint A; Gislum M; Hakulinen T; Engholm G; Tryggvadóttir L; Storm HH
Acta Oncol; 2010 Jun; 49(5):644-54. PubMed ID: 20151937
[TBL] [Abstract][Full Text] [Related]
3. Conditional cancer-specific mortality in T4, N1, or M1 prostate cancer: implications for long-term prognosis.
Muralidhar V; Mahal BA; Nguyen PL
Radiat Oncol; 2015 Jul; 10():155. PubMed ID: 26220664
[TBL] [Abstract][Full Text] [Related]
4. The National Prostate Cancer Register in Sweden 1998-2002: trends in incidence, treatment and survival.
Varenhorst E; Garmo H; Holmberg L; Adolfsson J; Damber JE; Hellström M; Hugosson J; Lundgren R; Stattin P; Törnblom M; Johansson JE
Scand J Urol Nephrol; 2005; 39(2):117-23. PubMed ID: 16019764
[TBL] [Abstract][Full Text] [Related]
5. Differences in survival from prostate cancer in Denmark, Iceland and Sweden.
Brasso K; Ingimarsdóttir IJ; Rusch E; Engholm G; Adolfsson J; Tryggvadóttir L; Jónsson E; Bill-Axelson A; Holmberg E; Storm HH
Eur J Cancer; 2013 May; 49(8):1984-92. PubMed ID: 23453749
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005.
Adolfsson J; Garmo H; Varenhorst E; Ahlgren G; Ahlstrand C; Andrén O; Bill-Axelson A; Bratt O; Damber JE; Hellström K; Hellström M; Holmberg E; Holmberg L; Hugosson J; Johansson JE; Petterson B; Törnblom M; Widmark A; Stattin P
Scand J Urol Nephrol; 2007; 41(6):456-77. PubMed ID: 17934985
[TBL] [Abstract][Full Text] [Related]
7. Trends in prostate cancer survival in Sweden, 1960 through 1988: evidence of increasing diagnosis of nonlethal tumors.
Helgesen F; Holmberg L; Johansson JE; Bergström R; Adami HO
J Natl Cancer Inst; 1996 Sep; 88(17):1216-21. PubMed ID: 8780631
[TBL] [Abstract][Full Text] [Related]
8. A natural history model for planning prostate cancer testing: Calibration and validation using Swedish registry data.
Karlsson A; Jauhiainen A; Gulati R; Eklund M; Grönberg H; Etzioni R; Clements M
PLoS One; 2019; 14(2):e0211918. PubMed ID: 30763406
[TBL] [Abstract][Full Text] [Related]
9. Patients with prostate cancer continue to have excess mortality up to 15 years after diagnosis.
Husson O; van Steenbergen LN; Koldewijn EL; Poortmans PM; Coebergh JW; Janssen-Heijnen ML
BJU Int; 2014 Nov; 114(5):691-7. PubMed ID: 24131890
[TBL] [Abstract][Full Text] [Related]
10. Comparison of prostate cancer survival in Germany and the USA: can differences be attributed to differences in stage distributions?
Winter A; Sirri E; Jansen L; Wawroschek F; Kieschke J; Castro FA; Krilaviciute A; Holleczek B; Emrich K; Waldmann A; Brenner H;
BJU Int; 2017 Apr; 119(4):550-559. PubMed ID: 27208546
[TBL] [Abstract][Full Text] [Related]
11. The Risk of Distant Metastases and Cancer Specific Survival in Men with Serum Prostate Specific Antigen Values above 100 ng/ml.
Stattin K; Sandin F; Bratt O; Lambe M
J Urol; 2015 Dec; 194(6):1594-600. PubMed ID: 26192253
[TBL] [Abstract][Full Text] [Related]
12. Trends in the overall survival of cancer patients diagnosed 1964-2003 in the Nordic countries followed up to the end of 2006: the importance of case-mix.
Storm HH; Kejs AM; Engholm G; Tryggvadóttir L; Klint A; Bray F; Hakulinen T
Acta Oncol; 2010 Jun; 49(5):713-24. PubMed ID: 20491527
[TBL] [Abstract][Full Text] [Related]
13. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
14. Opportunistic testing versus organized prostate-specific antigen screening: outcome after 18 years in the Göteborg randomized population-based prostate cancer screening trial.
Arnsrud Godtman R; Holmberg E; Lilja H; Stranne J; Hugosson J
Eur Urol; 2015 Sep; 68(3):354-60. PubMed ID: 25556937
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and survival in node-positive (N1) prostate cancer-a prospective study based on data from a Swedish population-based cohort.
Aus G; Nordenskjöld K; Robinson D; Rosell J; Varenhorst E
Eur Urol; 2003 Jun; 43(6):627-31. PubMed ID: 12767363
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer diagnosed after prostate-specific antigen testing of men without clinical signs of the disease: a population-based study from the National Prostate Cancer Register of Sweden.
Bratt O; Berglund A; Adolfsson J; Johansson JE; Törnblom M; Stattin P;
Scand J Urol Nephrol; 2010 Dec; 44(6):384-90. PubMed ID: 20624113
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based study.
Rider JR; Sandin F; Andrén O; Wiklund P; Hugosson J; Stattin P
Eur Urol; 2013 Jan; 63(1):88-96. PubMed ID: 22902040
[TBL] [Abstract][Full Text] [Related]
18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
19. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
20. Non-systematic screening for prostate cancer in Sweden--survey from the National Prostate Cancer Registry.
Stattin P; Johansson R; Damber JE; Hellström M; Hugosson J; Lundgren R; Varenhorst E; Johansson JE
Scand J Urol Nephrol; 2003; 37(6):461-5. PubMed ID: 14675917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
